Source link : https://newshealth.biz/health-news/sibeprenlimab-halves-upcr-in-iga-nephropathy-trial/
VIENNA — Sibeprenlimab, a novel selective immune antibody, reduced the urine protein-to-creatinine ratio (uPCR) by more than half in patients with immunoglobulin A (IgA) nephropathy, according to an interim analysis of the VISIONARY trial. Beyond this clinical effect, a notable observation was the lack of safety concerns, especially given that, although sibeprenlimab is a selective […]
The post Sibeprenlimab Halves uPCR in IgA Nephropathy Trial first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-06 18:43:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8